Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196,609 | -21.7% | 36,075 | -2.4% | 0.00% | – |
| Q2 2023 | $251,040 | +1812.5% | 36,972 | +1311.1% | 0.00% | – |
| Q1 2023 | $13,126 | +123.8% | 2,620 | +118.0% | 0.00% | – |
| Q4 2022 | $5,866 | -100.0% | 1,202 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $19,877,000 | -33.3% | 1,378,466 | -30.1% | 0.00% | -33.3% |
| Q2 2022 | $29,819,000 | +27.4% | 1,970,851 | +0.0% | 0.00% | +50.0% |
| Q1 2022 | $23,407,000 | -5.4% | 1,970,268 | +29.1% | 0.00% | 0.0% |
| Q4 2021 | $24,733,000 | -43.2% | 1,525,787 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $43,546,000 | -16.8% | 1,525,787 | -1.5% | 0.00% | -25.0% |
| Q2 2021 | $52,356,000 | +11.8% | 1,548,987 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $46,841,000 | -6.1% | 1,548,987 | +53.8% | 0.00% | 0.0% |
| Q4 2020 | $49,865,000 | +16.5% | 1,007,174 | -9.6% | 0.00% | 0.0% |
| Q3 2020 | $42,791,000 | -24.4% | 1,114,642 | -15.0% | 0.00% | -33.3% |
| Q2 2020 | $56,624,000 | +56.0% | 1,310,742 | -5.8% | 0.01% | +20.0% |
| Q1 2020 | $36,301,000 | -16.5% | 1,390,842 | -0.0% | 0.01% | 0.0% |
| Q4 2019 | $43,471,000 | +2.6% | 1,391,061 | -14.5% | 0.01% | 0.0% |
| Q3 2019 | $42,390,000 | +13.9% | 1,626,642 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $37,201,000 | -12.7% | 1,626,642 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $42,634,000 | +28.9% | 1,626,642 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $33,086,000 | +1.2% | 1,626,642 | +32.2% | 0.01% | +25.0% |
| Q3 2018 | $32,686,000 | – | 1,230,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |